Health and Human Services Secretary Robert F. Kennedy Jr. said during a Senate Finance Committee hearing on Thursday that the previous administration of Joe Biden manipulated abortion pill safety data.
This manipulation is resulting in an apparent 22 times higher risk for serious complications than had been reported, Kennedy explained.
During questioning by Sen. James Lankford (R-OK) on the Trump administration’s health care agenda, the ongoing safety review of mifepristone, the first drug in a two-drug abortion regimen used by most women who seek abortions, was addressed.
In April, a study was released that showed nearly 11%, or one in nine women who take mifepristone, have a complication serious enough to seek emergency medical care.
Those complications included sepsis, infection, hemorrhaging, and other adverse events occurring within 45 days following the abortion.
Lankford pointed out that since Biden loosened the restrictions on abortion pills in the wake of Roe V. Wade’s overturning, “there’s all kinds of issues that are happening now on it.”
The abortion drugs are now available without a prescription to make them easier to get, except when state laws prohibit them.
“So the question was: you’d said that there would be a review on that, just to be able